AU2001297735A1 - In vitro transcribed retroviral genomes, methods for their production and methods of use - Google Patents

In vitro transcribed retroviral genomes, methods for their production and methods of use

Info

Publication number
AU2001297735A1
AU2001297735A1 AU2001297735A AU2001297735A AU2001297735A1 AU 2001297735 A1 AU2001297735 A1 AU 2001297735A1 AU 2001297735 A AU2001297735 A AU 2001297735A AU 2001297735 A AU2001297735 A AU 2001297735A AU 2001297735 A1 AU2001297735 A1 AU 2001297735A1
Authority
AU
Australia
Prior art keywords
methods
production
vitro transcribed
retroviral genomes
transcribed retroviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001297735A
Inventor
Jakob M. Bogenberger
James Lorens
Susan E. Swift
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rigel Pharmaceuticals Inc
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of AU2001297735A1 publication Critical patent/AU2001297735A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001297735A 2000-11-16 2001-11-16 In vitro transcribed retroviral genomes, methods for their production and methods of use Abandoned AU2001297735A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24972800P 2000-11-16 2000-11-16
US60/249,728 2000-11-16
PCT/US2001/043587 WO2002079482A2 (en) 2000-11-16 2001-11-16 In vitro transcribed retroviral genomes, methods for their production and methods of use

Publications (1)

Publication Number Publication Date
AU2001297735A1 true AU2001297735A1 (en) 2002-10-15

Family

ID=22944732

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001297735A Abandoned AU2001297735A1 (en) 2000-11-16 2001-11-16 In vitro transcribed retroviral genomes, methods for their production and methods of use

Country Status (2)

Country Link
AU (1) AU2001297735A1 (en)
WO (1) WO2002079482A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015028683A1 (en) * 2013-09-02 2015-03-05 Cellectis Rna based method to obtain stably integrated retroviral vectors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001032A3 (en) * 1989-08-18 2005-02-23 Chiron Corporation Recombinant retroviruses delivering vector constructs to target cells
US6489167B1 (en) * 1996-09-25 2002-12-03 The Government Of The United States As Represented By The Secretary Of The Department Of Human Services Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic Togavirus vectors
NZ500740A (en) * 1997-05-13 2001-02-23 Univ North Carolina Recombinant lentivirus-based gene transfer vectors comprising 3 vectors from Equine Infectious Anemia Virus (EIAV)
GB2334257B (en) * 1997-12-22 2001-07-04 Oxford Biomedica Ltd Rectroviral vectors

Also Published As

Publication number Publication date
WO2002079482A3 (en) 2004-02-26
WO2002079482A2 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
AU2001296809A1 (en) Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2001227573A1 (en) Ceramics and process for producing
AU2002236524A1 (en) In vitro transcription method for rna amplification
AU2001288249A1 (en) Biosensors and methods for their use
AU2002217226A1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
AU2002233670A1 (en) Process for producing perfluorocarbons and use thereof
AU2001255767A1 (en) Methods and reagents for tissue engineering of cartilage in vitro
AU2001289684A1 (en) Glass-ceramics, process for their preparation and use
AU2002321292A1 (en) Hybrid membrane, method for the production thereof and use of said membrane
AU2002211736A1 (en) Methods for synthesizing precipitated silica and use thereof
AU2001280179A1 (en) Production and use of octafluoropropane
AU2002211183A1 (en) Prosthetic construct and methods for its manufacture and use
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2003244727A1 (en) Novel podophyllotoxin derivatives, the production thereof and the use of the same in therapeutics
AU2001291688A1 (en) (meth)acrylic acid derivatives and their polymers suitable for use in the manufacture of paper
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2001279537A1 (en) Method and arrangement for the production of crossed stacks
AUPQ583100A0 (en) Fastening apparatus and methods for their production and use
AU2001297735A1 (en) In vitro transcribed retroviral genomes, methods for their production and methods of use
AU2001272757A1 (en) Process for producing 5-fluorooxyindole and for producing intermediate therefor
AU2001261489A1 (en) Methods for the production of d-chiro-inositol and the use of d-chiro-inositol obtained therefrom
AU2001262229A1 (en) Cyclipostins, a method for their production and the use of the same
AUPQ952100A0 (en) Membranes and method of manufacture thereof
AU2003245468A1 (en) Materials and methods for in vitro production of bacteria

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase